PRISM Biotech
New York, March 21, 2024 - PRISM MarketView - Enveric Biosciences (Nasdaq: ENVB) has signed three non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of three classes of compounds. The compounds are from Enveric’s extensive libra...

21 March 2024

PRISM Biotech
New York, March 20, 2024 - PRISM MarketView - Psychedelic drug company, Clearmind Medicine Inc. (Nasdaq: CMND), has received approval from the Israeli Ministry of Health to commence its Phase 1/2a clinical trial for alcohol use disorder (AUD) patients.

20 March 2024

PRISM Cannabis
New York, March 20, 2024 - PRISM MarketView - Global medical cannabis company, Aurora Cannabis (Nasdaq: ACB) has received a landmark certification from Australian authorities for cannabis products from its Canadian production facilities. The company announced on Wednesda...

20 March 2024

PRISM View
New York, March 20, 2024 - PRISM MarketView - Golf lifestyle, equipment and apparel company TopGolf Callaway (MODG) is taking a play from recent PLAYERS Champ Scottie Scheffler and winning on the day as its moving into the green trading up ~12% and leading the PRISM Cons...

20 March 2024

PRISM AI
New York, March 20, 2024 - PRISM MarketView - In today’s world of AI and technology, there are some memories of the past that still hold a true nostalgia for the more simplistic times that once existed. 39 years ago, a film known as The Breakfast Club was released that s...

20 March 2024

PRISM Markets
New York, March 20, 2024 - PRISM MarketView - Oil and natural gas producer, W&T Offshore (NYSE: WTI), has announced modifications to the first-lien non-recourse term loan between its wholly-owned special purpose vehicles and Munich Re Reserve Risk Financing. The modi...

20 March 2024

PRISM Biotech
New York, March 19, 2023 - PRISM MarketView - Clinical stage biopharmaceutical company,  ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA), has received Institutional Review Board (IRB) approval of its Phase 2a clinical trial protocol to evaluate the efficacy and safety of Chole...

19 March 2024

PRISM Biotech
New York, March 19, 2023 - PRISM MarketView - Anavex Life Sciences (Nasdaq: AVXL) has screened the first patient in its Phase 2 clinical study of ANAVEX®3-71 for the treatment of schizophrenia, ahead of schedule. ANAVEX®3-71’s differentiated mechanism is a dual SIGMAR1 r...

19 March 2024

PRISM Biotech
New York, March 19, 2023 - PRISM MarketView - Marvel Biosciences Corp. (OTCQB: MBCOF) has reported promising interim results from its study on MB-204, a new treatment for autism. The study, being conducted by the iBrain Institute in Tours, France, has demonstrated that a...

19 March 2024

PRISM Biotech
New York, March 18, 2023 - PRISM MarketView - SciSparc Ltd. (Nasdaq: SPRC) has successfully dosed the first patient in its SCI-210 clinical trial for pediatric patients with Autism Spectrum Disorder (ASD). This is a significant milestone for the company as it evaluates i...

18 March 2024

41
42
43
44
45
46
47
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.